NEW YORK, July 29, 2013 /PRNewswire/ -- ICAP Patent Brokerage announces for sale five innovative electronic cigarette patent portfolios, which include technologies for e-cigarettes and their accessories.
According to Wall Street estimates, U.S. e-cigarette retail sales are expected to grow from $500 million in 2012 to $1 billion in 2013, and eclipse U.S. traditional cigarette market sales within the next decade. Further, a steadily increasing portion of income from this emerging market will be from e-cigarette accessories such as the cartridges that hold the required e-cigarette operating fluid known as "e-juice" or "e-liquid."
"Despite recent market growth and product innovation, few companies have developed sizeable intellectual property positions in this space; with fierce competition for IP expected in the near future. Therefore, owning one or all of these portfolios will provide a distinct advantage to first movers interested in joining this promising market," says Dean Becker, CEO of ICAP Patent Brokerage.
Key Characteristics & Benefits
PS 664 – Electronic Cigarettes: The portfolio for sale describes improved e-cigarette technology designed to have an appearance, taste, and aroma identical to that of tobacco cigarettes. This e-cigarette generates visible and dense smoke and includes aerosol chambers with valves to control the amount of smoke inhaled by users. Additional substances such as fragrances, nicotine, and pharmaceuticals can be included in the e-cigarette that may provide assistance in the cessation of smoking.
PS 678 – Electronic Cigarettes with Sealed Tank Cartridge: This IP package includes electronic cigarettes with a sealed tank cartridge design. The e-liquid in the tank cartridge remains pure as it does not mix with the heated wires and smoldering points of the e-cigarette, preventing the inhalation of lead or contact with potentially harmful vapors. The liquid used by the disclosed cigarette does not evaporate quickly, and remains fresh for up to three years; compared to only a few months for similar products on the market.
PS 675 – Smokeless & Heatless Electronic Cigarettes: The unique smoking substitute offered in this portfolio operates using inhaled air rather than cartridges or batteries that require replacement, making it more cost-effective than existing e-cigarettes. Plus, this smokeless cigarette can be used anywhere without restriction as it does not emit any smoke, mist, or odor.
PS 679 – Electronic Cigarette "E-Juice" Cartridge Refill: The patent for sale offers a safe and effective solution for refilling electronic cigarette e-juice with precision dispensing that can be made for 1/10 the cost of current refill technology. Designed to work with existing electronic cigarette systems, the dispenser is a pre-filled, hermetically sealed pipette with a precise, long-neck dropper and soft squeeze bulb for control of dispensing even the smallest singular drops of e-juice.
PS 681 – Portable Medicinal Nebulizer: This portfolio discloses a compact and portable nebulizer designed to deliver traditional respiratory medicines as well as a range of non-respiratory drugs, supplements, and other agents. The device also provides a programmable user interface that enables a doctor or user to remotely monitor and record dosage information. The chamber of the nebulizer is detachable and replaceable, enabling administration of different drugs or gradually increasing or decreasing dosages while using the same device.
Click here to see a complete catalog of e-cigarette technology acquisition opportunities.
To learn more about the assets available for sale in this portfolio:
Contact Cam Rathborne of ICAP Patent Brokerage at (310) 909-9007 or via email at Cam.Rathborne@us.icap.com.
About ICAP Patent Brokerage
ICAP Patent Brokerage is a division of ICAP plc and the world's largest intellectual property brokerage and patent auction firm.
ICAP is a leading markets operator and provider of post trade risk mitigation and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through its post trade risk mitigation and information services ICAP helps customers manage and mitigate risks in their portfolios. For more information, go to www.icap.com.
SOURCE ICAP Patent Brokerage